Related Experiment Video
Updated: Mar 8, 2026

05:52
Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
1.1K
Clinically mild infantile encephalopathy associated with excitotoxicity
Nozomi Hirai1, Daisuke Yoshimaru2, Yoko Moriyama1
1Department of Pediatrics, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan.
Journal of the Neurological Sciences
|January 30, 2017
Summary
This study investigated unclassified acute encephalopathy in children. Increased brain glutamine suggests excitotoxicity may underlie some mild cases, with patients showing full recovery.
Area of Science:
- Pediatric Neurology
- Neuroscience
- Biochemistry
Background:
- Acute infectious encephalopathy is common in East Asian children.
- Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a frequent subtype in Japan.
- Over 40% of acute encephalopathy cases remain unclassified into specific syndromes.
Purpose of the Study:
- To investigate the pathomechanism of unclassified acute encephalopathy in children.
- To evaluate brain metabolism using MR spectroscopy in these patients.
Main Methods:
- MR spectroscopy was performed on 8 pediatric patients with unclassified acute encephalopathy.
- Brain metabolism was assessed by measuring levels of specific metabolites.
Main Results:
- Three of the 8 patients showed increased glutamine with normal N-acetyl aspartate levels.
- These metabolic changes were observed between days 3 to 8 and normalized upon follow-up.
- The three affected patients achieved complete clinical recovery.
Conclusions:
- Increased glutamine suggests excitotoxicity as a potential pathomechanism in some cases of unclassified mild encephalopathy.
- This finding offers insight into the underlying processes of these challenging neurological conditions.
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Epilepsy and Seizures: Overview
1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.5K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K

